🔎 Trials Near Me

Akèy › Ateroskleroz › South Carolina

Etid klinik pou Ateroskleroz nan South Carolina

6 etid pou Ateroskleroz ap chèche patisipan nan sit nan South Carolina.

Vil nan South Carolina

Tèks ofisyèl etid la (Anglè)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Monroe Biomedical Research - Charleston, North Charleston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • M3 Wake Research - Charleston, Charleston
  • Medical University of South Carolina, Charleston
  • Walker Family Care, Little River
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Accellacare Charleston, Mt. Pleasant
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Columbia Nephrology, Columbia
  • CN Clinical Research LLC, Greenville
  • Dialysis Clinic, Inc., Spartanburg
  • ak 1 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Charleston
  • Research Site, Fort Mill
  • Research Site, Mauldin
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
  • Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC, Columbia
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT02915198

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.